Use of NSAIDs, smoking and lung cancer risk

British Journal of Cancer

Volumn 98, Issue 1, 2008, Pages 232-237

  Olsen, J H ^a   Friis, S ^a   Poulsen, A H ^a   Fryzek, J ^b   Harving, H ^c   Tjonneland A ^a   Sorensen H T ^d   Blot, W ^b,e  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Chemoprevention; Lung cancer; Non steroidal anti inflammatory drugs; Pharmacoepidemiology

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; CANCER RISK; DATA BASE; DENMARK; DRUG EFFECT; DRUG USE; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SELF REPORT; SMOKING HABIT;

ADULT; AGE DISTRIBUTION; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; SMOKING;

EID: 38049037006     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604151     Document Type: Article

References (29)

1. Akhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, Koenig KL, Shore RE (2002) Aspirin and lung cancer in women. Br J Cancer 87: 49-53
2. Capellá D (1993) Descriptive tools and analysis. In Drug Utilization Studies: Methods and Uses, Dukes MNG (ed) pp 639-643. Geneva: World Health Organization (European Series No. 45)
3. Castonguay A, Rioux N, Duperron C, Jalbert G (1998) Inhibition of lung tumorigenesis by NSAIDs: a working hypothesis. Exp Lung Res 24: 605-615
4. Cook NR, Lee I-M, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE (2007) Low-dose aspirin in the primary prevention of cancer. JAMA 294: 47-55
5. Friis S, Sørensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH (2003) A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 88: 684-688
6. Gaist D, Sørensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44: 445-448
7. Harris RE, Beebedonk J, Schuller HM (2002) Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep 9: 693-695
8. Hayes JH, Anderson E, Folsom AR (2006) Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 15: 2226- 2231
9. Hernández-Diaz S, Rodriguez G (2007) Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer 120: 1565-1572
10. Holick CN, Michaud DS, Leitzmann MF, Willett WC, Giovannucci E (2003) Aspirin use and lung cancer in men. Br J Cancer 89: 1705-1708
11. Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y, Ochiai A (2000) Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 30: 73-81
12. Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley J, Calle EE (2007) A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99: 608-615
13. Langman MJS, Cheng KK, Gilman EA, Lancashire RJ (2000) Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general research database. Br Med J 320: 1642-1646
14. Lee JE, Manson JE, Hennekens CH, Buring JE (1995) Low-dose aspirin and risk of cancer: the physician's health study (abstract). Am J Epidemiol 141: S28
15. Mellemkjær L, Blot WJ, Sørensen HT, Thomassen L, McLaughlin JK, Nielsen GL, Olsen JH (2002) Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 53: 173-181
16. Moysich KB, Menezes RJ, Ronsani A, Swede H, Reid ME, Cummings KM, Falkner KL, Loewen GM, Bepler G (2002) Regular aspirin use and lung cancer risk. BMC Cancer 2: 31
17. Muscat JE, Chen S, Richie JP, Altorki NK, Citron M, Olson S, Neugut AI, Stellman SD (2003) Risk of lung carcinoma among users of nonsteroidal anti-inflammatory drugs. Cancer 97: 1732-1736
18. Paganini-Hill A, Chao A, Ross RK, Henderson BE (1989) Aspirin use and chronic disease: a cohort study of the elderly. Br Med J 299: 1247-1250
19. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C (1988) Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 296: 313-316
20. Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taulor PR, Hawk E (2004) Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 24: 3177-3184
21. Rosenberg L (1995) Nonsteroidal anti-inflammatory drugs and cancer. Prev Med 24: 107-109
22. Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138-146
23. Skriver MV, Nørgaard M, Poulsen AH, Friis S, Harving H, Fryzek J (2005) Use of nonaspirin NSAIDs and risk of lung cancer. Int J Cancer 117: 873-876
24. Sørensen HT, Friis S, Nørgaard B, Mellemkjær L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA (2003) Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88: 1687-1692
25. Thun M, Henley S, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistics, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266
26. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath Jr CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322-1327
27. Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjær L (2004) Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 100: 2328-2337
28. Tjønneland A, Overvad K, Haraldsdottir J, Bang S, Ewertz M, Jensen OM (1991) Validation of a semiquantitative food frequency questionnaire developed in Denmark. Int J Epidemiol 20: 906-912
29. Wall RJ, Shyr Y, Smalley W (2007) Nonsteroidal anti-inflammatory drugs and lung cancer risk: a population-based case-control study. J Thorac Onco 2: 109-114